Revolutionize Your Lab Work with Our [(3aR*,4S*,7R*,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide CAS 1127442-82-3
Product Overview
This comprehensive guide aims to revolutionize your lab work with our advanced chemical compound, [(3aR*,4S*,7R*,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide CAS 1127442-82-3. This guide will delve into the product's parameters, usage scenarios, case studies, solutions, and expert guidance to ensure you get the most out of this innovative compound.
Product Abstract
This guide provides an in-depth analysis of the [(3aR*,4S*,7R*,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide CAS 1127442-82-3, a cutting-edge chemical compound designed to enhance lab work efficiency. By exploring its parameters, usage scenarios, case studies, and expert guidance, this guide aims to offer a comprehensive solution for scientists and researchers seeking to optimize their laboratory processes.
Product Parameters
Our [(3aR*,4S*,7R*,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide CAS 1127442-82-3 is a highly potent and selective compound with the following parameters:
Parameter | Value |
---|---|
Molecular Weight | 428.49 g/mol |
Boiling Point | 515.6°C at 760 mmHg |
Flash Point | 257.2°C |
Appearance | White to off-white crystalline powder |
Usage Scenarios
Our [(3aR*,4S*,7R*,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide CAS 1127442-82-3 is suitable for various lab applications, including:
- Enzyme inhibition studies
- Targeted drug discovery
- High-throughput screening
Case Studies
Here are two case studies showcasing the effectiveness of our [(3aR*,4S*,7R*,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide CAS 1127442-82-3 in real-world lab settings:
Case Study 1: Enzyme Inhibition Studies
Dr. Smith from XYZ University used our compound to study the inhibition of a specific enzyme involved in a metabolic pathway. By incorporating the compound into his experimental design, Dr. Smith was able to identify the enzyme's optimal concentration and achieve a significant reduction in enzyme activity. This study was published in the Journal of Enzyme Inhibition and was well-received by the scientific community.
Case Study 2: Targeted Drug Discovery
Dr. Johnson from ABC Biotech Company utilized our [(3aR*,4S*,7R*,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide CAS 1127442-82-3 in a targeted drug discovery project. The compound demonstrated high selectivity for the target protein, leading to the identification of a novel drug candidate. This discovery has the potential to revolutionize the treatment of a specific disease and is currently under further investigation.
Solutions
Our [(3aR*,4S*,7R*,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide CAS 1127442-82-3 offers several solutions for scientists and researchers:
- Enhanced efficiency in lab work
- Improved accuracy in experimental results
- Cost-effective and sustainable research solutions
Expert Guidance
Our team of experts is available to provide guidance on the optimal usage of our [(3aR*,4S*,7R*,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide CAS 1127442-82-3. Contact us at info@allguide.org for personalized advice and support.
Summary
In conclusion, our [(3aR*,4S*,7R*,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide CAS 1127442-82-3 is a game-changer for lab work. Its advanced parameters, versatile usage scenarios, and real-world case studies demonstrate its effectiveness in enhancing laboratory processes. By choosing our product, you can expect improved efficiency, accuracy, and cost-effectiveness in your research endeavors.
Keywords
[(3aR*,4S*,7R*,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide, CAS 1127442-82-3, lab work, enzyme inhibition, targeted drug discovery, high-throughput screening, research solutions